PCCA

UniProt ID: P05165
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

PCCA encodes the biotin-containing alpha subunit of mitochondrial propionyl-CoA carboxylase (PCC; EC 6.4.1.3), a biotin-dependent carboxylase of the mitochondrial matrix. PCC catalyses the first, committed, ATP-dependent step of propionyl-CoA catabolism, converting propanoyl-CoA + bicarbonate + ATP into (S)-methylmalonyl-CoA + ADP + phosphate; the methylmalonyl-CoA product is subsequently converted to succinyl-CoA and enters the tricarboxylic acid cycle. Propionyl-CoA arises from the catabolism of the amino acids isoleucine, valine, methionine and threonine, of odd-chain fatty acids, and of cholesterol. The functional holoenzyme is a large alpha6-beta6 dodecamer (~750 kDa) built from six PCCA (alpha) and six PCCB (beta) subunits. The alpha subunit carries the biotin carboxylase (BC) domain and the C-terminal biotin-carboxyl-carrier-protein (BCCP) domain to which biotin is covalently attached (at Lys694, by holocarboxylase synthetase); it binds ATP and bicarbonate and catalyses the Mg2+-dependent carboxylation of biotin, whereas the beta subunit (PCCB) supplies the carboxyltransferase activity that transfers the carboxyl group to propionyl-CoA. The alpha subunit is synthesized with a cleavable N-terminal mitochondrial targeting presequence and matures in the matrix. Loss of PCC activity through biallelic pathogenic variants in PCCA (or PCCB) causes propionic acidemia, an autosomal recessive organic acidemia.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004658 propionyl-CoA carboxylase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred propionyl-CoA carboxylase activity. This is the core, defining molecular function of PCCA as the biotin-containing alpha subunit of the PCC holoenzyme, directly supported by biochemistry and disease genetics.
Reason: Well-supported core function; the IBA is at the correct level of specificity and concordant with experimental (IDA/IMP) annotations and the EC 6.4.1.3 assignment.
Supporting Evidence:
PMID:29033250
Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation of propionyl-CoA to methylmalonyl-CoA and is encoded by the genes PCCA and PCCB to form a hetero-dodecamer.
GO:0005739 mitochondrion
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically inferred mitochondrial localization/activity. Correct: PCC is a mitochondrial matrix enzyme.
Reason: Consistent with experimental matrix localization (below); mitochondrion is a correct, if less specific, compartment for where the enzyme is active.
Supporting Evidence:
PMID:20725044
Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme, is essential for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol and fatty acids with an odd number of carbon atoms.
GO:0004658 propionyl-CoA carboxylase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (RHEA:23720 / EC 6.4.1.3 mapping) assignment of propionyl-CoA carboxylase activity. Redundant with, and confirmed by, the experimental IDA/IMP annotations of the same term.
Reason: Correct core molecular function; the EC/RHEA mapping matches the demonstrated catalytic activity.
Supporting Evidence:
PMID:6765947
We have purified propionyl-CoA carboxylase from normal, postmortem human liver to homogeneity.
GO:0005524 ATP binding
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro-based ATP binding. The alpha subunit contains an ATP-grasp domain and catalyses the ATP-dependent carboxylation of biotin; ATP is a substrate of the BC reaction (Km ~0.08 mM).
Reason: Supported by the catalytic mechanism, the ATP-grasp domain, and multiple ATP binding-site features in UniProt; ATP binding is integral to the alpha-subunit biotin carboxylase step.
Supporting Evidence:
PMID:6765947
The apparent Km values for ATP, propionyl-CoA, and bicarbonate are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
GO:0005759 mitochondrial matrix
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic (UniProt subcellular location / ARBA) assignment of mitochondrial matrix. Correct and concordant with experimental EXP/IDA matrix annotations.
Reason: PCC is a matrix enzyme; the electronic assignment matches the curated UniProt subcellular location and experimental evidence.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
GO:0009374 biotin binding
IEA
GO_REF:0000117
ACCEPT
Summary: ARBA electronic assignment of biotin binding. Biotin is the obligate cofactor of PCC and is covalently attached to the C-terminal biotinyl domain of the alpha subunit; each holoenzyme carries biotin almost entirely on the alpha subunit.
Reason: Strongly supported: biotin is the defining cofactor of this biotin-dependent carboxylase and is carried by PCCA.
Supporting Evidence:
PMID:6765947
Each mole of native enzyme contains 4 mol of bound biotin, virtually all of which is found with the larger (alpha) subunit.
GO:0016885 ligase activity, forming carbon-carbon bonds
IEA
GO_REF:0000117
ACCEPT
Summary: ARBA electronic assignment of the parent ligase term. This is the correct broad catalytic class (EC 6.4 ligases forming C-C bonds) for propionyl-CoA carboxylase, but is less informative than the specific GO:0004658 already annotated.
Reason: Correct parent activity; not wrong, but subsumed by the more specific propionyl-CoA carboxylase activity. Retained as a valid, if general, IEA.
Supporting Evidence:
PMID:29033250
Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation of propionyl-CoA to methylmalonyl-CoA
GO:0046872 metal ion binding
IEA
GO_REF:0000002
ACCEPT
Summary: InterPro-based metal ion binding. The alpha-subunit biotin carboxylase/ATP-grasp domain binds two divalent metal ions (Mg2+ or Mn2+) per subunit that are required for the ATP-dependent carboxylation step.
Reason: Supported by UniProt cofactor annotation (binds 2 Mg2+/Mn2+ per subunit) and metal-binding site features; a general but correct molecular function.
Supporting Evidence:
PMID:20725044
The active site of the BC domain is conserved with that of E. coli BC, and all the residues that interact with the substrates of this reaction have essentially the same conformation in both structures
GO:0005515 protein binding
IPI
PMID:20725044
Crystal structure of the alpha(6)beta(6) holoenzyme of propi...
MARK AS OVER ANNOTATED
Summary: IntAct-curated binary interaction with PCCB (P05166), the beta subunit. This is the genuine, obligate holoenzyme partnership (alpha6-beta6), but the bare "protein binding" term is uninformative about the actual molecular function.
Reason: Per curation policy, bare protein binding IPIs are not removed. The interaction itself (with PCCB) is real and biologically central, but "protein binding" adds no functional specificity beyond what is captured by the propionyl-CoA carboxylase complex membership; a more informative term (structural constituent of the PCC holoenzyme) would be preferable.
Supporting Evidence:
PMID:20725044
The holoenzyme of PCC is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: IntAct/HuRI systematic binary interactome hit, here with MCC (MCCC1, P23508), a paralogous biotin-dependent carboxylase. Bare "protein binding" from a high-throughput all-by-all screen.
Reason: Uninformative term from a proteome-scale Y2H screen; not the core function. Retained per policy (not removed) but flagged as over-annotation.
Supporting Evidence:
PMID:32296183
Here we present a human 'all-by-all' reference interactome map of human binary protein interactions, or 'HuRI'.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: IntAct-curated interaction with PCCB (P05166) from a proteome-scale interactome study (BioPlex-type). Again the genuine beta-subunit partner, reported via the uninformative "protein binding" term.
Reason: Real interaction (PCCB, the holoenzyme partner) but bare protein binding is not the core molecular function; retained per policy and flagged as over-annotation.
Supporting Evidence:
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling of the human
GO:0005515 protein binding
IPI
PMID:40205054
Multimodal cell maps as a foundation for structural and func...
MARK AS OVER ANNOTATED
Summary: IntAct-curated interaction with PCCB (P05166) from a multimodal cell-map / genomics study. The beta-subunit partner again, via bare "protein binding".
Reason: Genuine PCCB partnership but uninformative term; retained per policy and flagged as over-annotation rather than removed.
Supporting Evidence:
PMID:40205054
Multimodal cell maps as a foundation for structural and functional genomics.
GO:0005739 mitochondrion
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence (Human Protein Atlas) localization to mitochondrion. Correct, if less specific than the matrix annotations.
Reason: Direct localization evidence consistent with PCC being a mitochondrial matrix enzyme.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
GO:0005759 mitochondrial matrix
NAS
PMID:29033250
Propionyl-CoA carboxylase - A review.
ACCEPT
Summary: ComplexPortal (CPX-6169) NAS assignment of mitochondrial matrix, from the PCC review. Correct compartment for the holoenzyme.
Reason: Concordant with experimental EXP/IDA matrix evidence and the curated UniProt subcellular location.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
GO:0006631 fatty acid metabolic process
NAS
PMID:29033250
Propionyl-CoA carboxylase - A review.
KEEP AS NON CORE
Summary: ComplexPortal NAS: PCC participates in fatty acid metabolism, since propionyl-CoA is the end product of beta-oxidation of odd-chain fatty acids and PCC channels it into the TCA cycle. Broad process term.
Reason: Real but non-core physiological context. PCC acts on the propionyl-CoA node of odd-chain fatty acid catabolism; the direct reaction is more precisely propionyl-CoA carboxylation/propionate catabolism than generic fatty acid metabolism.
Supporting Evidence:
PMID:29033250
Disruption of PCC leads to accumulation of odd-chain fatty acids (FA), as propionyl-CoA is the end product of beta oxidation of odd-numbered FA.
GO:0009081 branched-chain amino acid metabolic process
NAS
PMID:29033250
Propionyl-CoA carboxylase - A review.
KEEP AS NON CORE
Summary: ComplexPortal NAS: PCC is downstream in the catabolism of branched-chain and other amino acids (isoleucine, valine, methionine, threonine) that generate propionyl-CoA.
Reason: Valid physiological role (Ile and Val catabolism converge on propionyl-CoA), but not the direct reaction PCCA catalyses; kept as a relevant non-core process. Note GO:0009081 covers isoleucine/leucine/valine; PCC also serves Met/Thr, which are not branched-chain, so this term is a partial view of PCC's amino-acid role.
Supporting Evidence:
PMID:29033250
Propionyl-CoA is produced by catabolism of cholesterol, valine, odd chain fatty acids, methionine, isoleucine and threonine
GO:1902494 catalytic complex
IPI
PMID:20725044
Crystal structure of the alpha(6)beta(6) holoenzyme of propi...
ACCEPT
Summary: ComplexPortal IPI: PCCA is part of a catalytic complex, i.e. the alpha6-beta6 PCC holoenzyme (ComplexPortal CPX-6169, Mitochondrial propionyl-CoA carboxylase complex).
Reason: Correct: PCCA is an obligate structural subunit of the catalytic PCC holoenzyme. A dedicated "propionyl-CoA carboxylase complex" GO term does not currently exist (only acetyl-CoA and methylcrotonoyl-CoA carboxylase complexes), so the general "catalytic complex" is retained rather than modified to a nonexistent term.
Supporting Evidence:
PMID:20725044
The holoenzyme of PCC is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
GO:0005759 mitochondrial matrix
EXP
PMID:10101253
Genetic heterogeneity in propionic acidemia patients with al...
ACCEPT
Summary: Experimental import/localization: in vitro-expressed PCCA precursor is imported into mitochondria and processed to the mature matrix form. Supports mitochondrial matrix localization.
Reason: Direct experimental evidence for mitochondrial import and maturation, consistent with the matrix location of the enzyme.
Supporting Evidence:
PMID:10101253
Both wild-type and mutant proteins were imported into mitochondria and processed into the mature form with similar efficiency
GO:1901290 succinyl-CoA biosynthetic process
IDA
PMID:8434582
Cloning of functional alpha propionyl CoA carboxylase and co...
KEEP AS NON CORE
Summary: IDA (propionate-flux complementation) linking PCCA to production of succinyl-CoA. PCC catalyses the first step (propionyl-CoA -> methylmalonyl-CoA); succinyl-CoA is the downstream product of the three-step propanoyl-CoA degradation pathway.
Reason: PCC's direct product is (S)-methylmalonyl-CoA, not succinyl-CoA; succinyl-CoA formation requires the downstream MCEE and MUT steps. The annotation reflects PCCA's contribution to the pathway output rather than its direct catalytic product, so it is kept as non-core.
Supporting Evidence:
PMID:8434582
Both clones reconstitute propionate flux to normal levels in fibroblasts from patients genetically deficient in PCCA (pccA).
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
ACCEPT
Summary: High-throughput mitochondrial proteomics assignment to mitochondrion. Concordant with the established mitochondrial matrix localization.
Reason: High-confidence mitochondrial proteome evidence consistent with the curated compartment; correct though less specific than matrix.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics
GO:0005759 mitochondrial matrix
IDA
PMID:16023992
Mitochondrial targeting signals and mature peptides of 3-met...
ACCEPT
Summary: Direct evidence: the mature PCCA amino-terminus and cleavable N-terminal targeting presequence were defined, showing import into the mitochondrial matrix by the classical presequence pathway.
Reason: Experimental determination of the mitochondrial targeting signal and mature matrix peptide directly supports matrix localization.
Supporting Evidence:
PMID:16023992
the two subunits of the enzyme (MCCalpha; MCCbeta) are imported into the mitochondrial matrix by the classical pathway involving cleavable amino-terminal targeting presequences.
GO:0004658 propionyl-CoA carboxylase activity
IDA
PMID:6765947
Isolation and characterization of propionyl-CoA carboxylase ...
ACCEPT
Summary: Direct biochemical demonstration: PCC purified from human liver to homogeneity, shown to be a biotin-containing alpha/beta enzyme carboxylating propionyl-CoA with defined kinetic parameters. Core molecular function.
Reason: Definitive experimental evidence for propionyl-CoA carboxylase activity; anchors this as the core function of the enzyme.
Supporting Evidence:
PMID:6765947
The apparent Km values for ATP, propionyl-CoA, and bicarbonate are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
GO:0019626 short-chain fatty acid catabolic process
IC
PMID:6765947
Isolation and characterization of propionyl-CoA carboxylase ...
MODIFY
Summary: Curator inference (from GO:0004658) that PCC participates in short-chain fatty acid catabolism. Propionate/propionyl-CoA is a short-chain acid, but a more precise process term is available.
Reason: The reaction PCC catalyses is specifically the committed step of propionyl-CoA catabolism; "short-chain fatty acid catabolic process" is broader and less accurate than the dedicated term. Propose replacement with propionyl-CoA catabolic process.
Proposed replacements: propionyl-CoA catabolic process
Supporting Evidence:
PMID:29033250
PCC's primary function is to catalyze the carboxylation of propionyl-CoA to produce methylmalonyl-CoA
GO:0019626 short-chain fatty acid catabolic process
IC
PMID:8434582
Cloning of functional alpha propionyl CoA carboxylase and co...
MODIFY
Summary: Second curator inference (from GO:0004658) of short-chain fatty acid catabolism, based on the propionate-flux complementation study. Same over-broad term as above.
Reason: As above, the direct process is propionyl-CoA / propionate catabolism; replace the broad short-chain fatty acid term with the specific propionyl-CoA catabolic process.
Proposed replacements: propionyl-CoA catabolic process
Supporting Evidence:
PMID:8434582
Both clones reconstitute propionate flux to normal levels in fibroblasts from patients genetically deficient in PCCA (pccA).
GO:0004658 propionyl-CoA carboxylase activity
IMP
PMID:8434582
Cloning of functional alpha propionyl CoA carboxylase and co...
ACCEPT
Summary: IMP: recombinant human PCCA rescues (complements) the propionate-flux defect in PCCA-deficient (pccA) patient fibroblasts, demonstrating that PCCA is required for propionyl-CoA carboxylase activity in cells. Core molecular function.
Reason: Genetic complementation directly ties PCCA to the propionyl-CoA carboxylase activity and propionate flux; strong support for the core function.
Supporting Evidence:
PMID:8434582
We describe cDNA clones expressing human PCCA and complementation of the genetic defect in pccA fibroblasts by DNA-mediated gene transfer.
GO:0005829 cytosol
TAS
Reactome:R-HSA-2993447
KEEP AS NON CORE
Summary: Reactome TAS placing PCCA in the cytosol, reflecting the pre-import apo-precursor and the Reactome "HLCS biotinylates 6x(PCCA:PCCB)" / cytosolic-to-matrix translocation events. PCC is not catalytically active in the cytosol.
Reason: The functional, biotinylated, active holoenzyme resides in the mitochondrial matrix; the cytosolic assignment reflects the transient apo-precursor stage before mitochondrial import (any cytosolic biotinylation is likely non-functional). Kept as a non-core, transient localization rather than removed.
Supporting Evidence:
PMID:29033250
The PCCA precursor does not contain biotin until imported into the mitochondrion and cleaved
GO:0005829 cytosol
TAS
Reactome:R-HSA-3323111
KEEP AS NON CORE
Summary: Reactome TAS (cytosolic carboxylases translocate to mitochondrial matrix) placing the PCCA precursor in the cytosol prior to import.
Reason: As above: transient pre-import cytosolic localization of the apo-precursor; the active enzyme is a matrix enzyme. Non-core.
Supporting Evidence:
PMID:29033250
The PCCA precursor does not contain biotin until imported into the mitochondrion and cleaved
GO:0005829 cytosol
TAS
Reactome:R-HSA-9035990
KEEP AS NON CORE
Summary: Reactome TAS (defective HLCS does not biotinylate 6x(PCCA:PCCB)) placing PCCA in the cytosol as part of the biotinylation/multiple-carboxylase-deficiency pathway.
Reason: Same transient cytosolic apo-precursor context; not the functional compartment. Kept as non-core.
Supporting Evidence:
PMID:29033250
The PCCA precursor does not contain biotin until imported into the mitochondrion and cleaved
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-3065959
ACCEPT
Summary: Reactome TAS assignment of mitochondrial matrix (from the carboxylase degradation reaction). Correct functional compartment.
Reason: Concordant with experimental matrix evidence; the mature active enzyme is in the matrix.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-3323111
ACCEPT
Summary: Reactome TAS assignment of mitochondrial matrix (post-translocation destination in the cytosol->matrix translocation reaction). Correct functional compartment.
Reason: Matches the established matrix localization of the mature enzyme.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
GO:0005759 mitochondrial matrix
TAS
Reactome:R-HSA-71031
ACCEPT
Summary: Reactome TAS assignment of mitochondrial matrix, associated with the core PCC reaction (propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + Pi). This is the compartment where the catalytic reaction occurs.
Reason: Correct: the propionyl-CoA carboxylase reaction takes place in the mitochondrial matrix.
Supporting Evidence:
PMID:29033250
It is often described as a matrix enzyme because it can dissociate with sonication.
GO:0019899 enzyme binding
IPI
PMID:19157941
N- and C-terminal domains in human holocarboxylase synthetas...
KEEP AS NON CORE
Summary: IPI interaction with holocarboxylase synthetase (HLCS, P50747), the enzyme that covalently attaches biotin to PCCA. The study used the PCCA-derived C-terminal p67 polypeptide (biotinylation site K669/K694) as the HLCS substrate in Y2H and docking assays, defining the PCCA-HLCS substrate-enzyme interaction.
Reason: A real and biologically meaningful interaction (PCCA is the substrate of HLCS- mediated biotinylation, essential for activity), but it describes a post-translational modification relationship rather than PCCA's own core molecular function. "Enzyme binding" is more informative than bare protein binding, so it is retained as non-core.
Supporting Evidence:
PMID:19157941
The polypeptide p67 comprises the 67 C-terminal amino acids in human PCC (GenBank accession #AAA60035), including the biotin-binding site K669
GO:0009374 biotin binding
TAS
PMID:3460076
Isolation of cDNA clones coding for the alpha and beta chain...
ACCEPT
Summary: TAS (ProtInc) biotin binding, from the cDNA-cloning paper that identified the alpha chain via its conserved Ala-Met-Lys-Met biotin-binding-site motif. Biotin is the obligate cofactor carried by PCCA.
Reason: Well-established core cofactor relationship; the alpha chain was in fact identified through its biotin-binding-site sequence.
Supporting Evidence:
PMID:3460076
One class contained the anticipated Ala-Met-Lys-Met sequence, corresponding to the biotin binding site found in several biotin-dependent carboxylases, thus confirming the alpha-chain assignment of these clones.

Core Functions

Propionyl-CoA carboxylase alpha subunit: within the alpha6-beta6 PCC holoenzyme, the alpha subunit binds ATP and bicarbonate and catalyses the Mg2+-dependent ATP-driven carboxylation of its covalently bound biotin, contributing the biotin carboxylase half-reaction of propionyl-CoA carboxylase activity (conversion of propanoyl-CoA to (S)-methylmalonyl-CoA), the first committed step of propionyl-CoA / propionate catabolism in the mitochondrial matrix.

Supporting Evidence:
  • PMID:6765947
    The apparent Km values for ATP, propionyl-CoA, and bicarbonate are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
  • PMID:29033250
    PCC's primary function is to catalyze the carboxylation of propionyl-CoA to produce methylmalonyl-CoA

Biotin cofactor carrier: the alpha subunit carries the C-terminal biotinyl (BCCP) domain and binds biotin, which is covalently attached (by holocarboxylase synthetase) and is obligately required for catalytic activity of the biotin-dependent carboxylase.

Molecular Function:
biotin binding
Cellular Locations:
Supporting Evidence:
  • PMID:6765947
    Each mole of native enzyme contains 4 mol of bound biotin, virtually all of which is found with the larger (alpha) subunit.

ATP binding: the alpha subunit ATP-grasp/biotin carboxylase domain binds ATP (Km ~0.08 mM) as a substrate of the ATP-dependent biotin carboxylation step.

Molecular Function:
ATP binding
Cellular Locations:
Supporting Evidence:
  • PMID:6765947
    The apparent Km values for ATP, propionyl-CoA, and bicarbonate are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on curation of immunofluorescence data
Electronic Gene Ontology annotations created by ARBA machine learning models
Combined Automated Annotation using Multiple IEA Methods
Genetic heterogeneity in propionic acidemia patients with alpha-subunit defects. Identification of five novel mutations, one of them causing instability of the protein.
Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-CoA carboxylase.
N- and C-terminal domains in human holocarboxylase synthetase participate in substrate recognition.
Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase.
Propionyl-CoA carboxylase - A review.
A reference map of the human binary protein interactome.
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA and PCCB genes.
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.
Multimodal cell maps as a foundation for structural and functional genomics.
Isolation and characterization of propionyl-CoA carboxylase from normal human liver. Evidence for a protomeric tetramer of nonidentical subunits.
Cloning of functional alpha propionyl CoA carboxylase and correction of enzyme deficiency in pccA fibroblasts.
Reactome:R-HSA-2993447
HLCS biotinylates 6x(PCCA:PCCB)
Reactome:R-HSA-3065959
An unknown protease degrades hCBXs
Reactome:R-HSA-3323111
Cytosolic carboxylases translocate to mitochondrial matrix
Reactome:R-HSA-71031
propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + orthophosphate
Reactome:R-HSA-9035990
Defective HLCS does not biotinylate 6x(PCCA:PCCB)

Suggested Questions for Experts

Q: Do the three PCCA splice isoforms (P05165-1/-2/-3) differ in enzymatic function, holoenzyme incorporation, or tissue distribution? Their functional impact has not been well characterized.

Q: Does PCCA (or the PCC holoenzyme) have any moonlighting or regulatory role beyond carboxylation, e.g. via its reported acetylation/succinylation and interactions with SIRT3/4/5?

Suggested Experiments

Experiment: Isoform-resolved enzyme kinetics and holoenzyme-assembly assays for P05165-2 and P05165-3 versus the canonical isoform, to determine whether alternative splicing alters propionyl-CoA carboxylase activity.

Experiment: Quantitative biotinylation/acylation site mapping of PCCA in matched control and propionic-acidemia cells to test how post-translational modification state modulates PCC activity.

Deep Research

Falcon

(PCCA-deep-research-falcon.md)
Comprehensive Research Report: PCCA (Propionyl-CoA Carboxylase Alpha Chain, Mitochondrial) Falcon Edison Scientific Literature 33 citations 2 artifacts 2026-07-07T00:48:23.487410

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: PCCA (Propionyl-CoA Carboxylase Alpha Chain, Mitochondrial)

Gene: PCCA | UniProt: P05165 | EC: 6.4.1.3 | Organism: Homo sapiens

1. Gene and Protein Overview

The PCCA gene (HGNC:8653) is located on human chromosome 13 and encodes the alpha (Ξ±) subunit of propionyl-CoA carboxylase (PCC), a biotin-dependent mitochondrial enzyme (kelson1996chaperoninmediatedassemblyof pages 1-2). The Ξ± subunit has a molecular mass of approximately 70 kDa and is synthesized as a precursor protein containing an N-terminal mitochondrial targeting presequence of approximately 25 amino acids, which is proteolytically cleaved upon import into the mitochondrial matrix, yielding a mature protein beginning at residue 26 (kelson1996chaperoninmediatedassemblyof pages 2-3, kelson1996chaperoninmediatedassemblyof pages 1-2). The gene product functions together with the Ξ² subunit (encoded by PCCB) to form the active holoenzyme.

The following table summarizes the key properties of PCCA:

Property Summary
Gene name PCCA; encodes the mitochondrial propionyl-CoA carboxylase alpha chain in human, matching UniProt accession P05165 (kelson1996chaperoninmediatedassemblyof pages 1-2)
UniProt accession P05165 (user-provided target context)
Chromosomal location Chromosome 13 in human (kelson1996chaperoninmediatedassemblyof pages 1-2)
Protein size ~70 kDa alpha subunit of PCC (kelson1996chaperoninmediatedassemblyof pages 1-2)
Enzyme classification EC 6.4.1.3, propionyl-CoA carboxylase (erdal2025aminoacidmetabolism pages 9-10, kelson1996chaperoninmediatedassemblyof pages 1-2)
Cofactor Biotin; PCC is a biotin-dependent carboxylase (erdal2025aminoacidmetabolism pages 9-10, jitrapakdee2003thebiotinenzyme pages 4-6)
Reaction catalyzed Propionyl-CoA + HCO3βˆ’ + ATP β†’ D-methylmalonyl-CoA + ADP + Pi; ATP-dependent biotin-mediated carboxylation (erdal2025aminoacidmetabolism pages 9-10, kelson1996chaperoninmediatedassemblyof pages 1-2, zhou2024structuralinsightsinto pages 4-6)
Subcellular localization Mitochondrial matrix (kelson1996chaperoninmediatedassemblyof pages 1-2)
Mitochondrial targeting Synthesized as a precursor with an N-terminal mitochondrial leader/presequence; mature alpha subunit begins at about residue 26, implying a ~25 aa targeting peptide (kelson1996chaperoninmediatedassemblyof pages 2-3, kelson1996chaperoninmediatedassemblyof pages 1-2)
Holoenzyme assembly Ξ±6Ξ²6 dodecamer; four-layer architecture with six Ξ² subunits forming the core and Ξ± subunits arranged on top and bottom (kelson1996chaperoninmediatedassemblyof pages 1-2, zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4)
Key domains Alpha/PCCA: BC (biotin carboxylase), BT linker/hub domain, BCCP (biotin carboxyl carrier protein); Beta/PCCB: CT (carboxyltransferase) domain with CT-N and CT-C subdomains (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4, jitrapakdee2003thebiotinenzyme pages 4-6)
Primary metabolic pathway Propionate metabolism: propionyl-CoA β†’ D-methylmalonyl-CoA β†’ L-methylmalonyl-CoA β†’ succinyl-CoA, which enters the TCA cycle and supports gluconeogenesis (erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9)
Metabolic inputs to pathway Propionyl-CoA arises from catabolism of isoleucine, valine, threonine, methionine, odd-chain fatty acids, and cholesterol side chains (kelson1996chaperoninmediatedassemblyof pages 1-2, erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9)
Disease association Biallelic loss-of-function variants in PCCA cause propionic acidemia, a severe autosomal recessive organic acidemia with metabolic decompensation, neurologic disease, and cardiomyopathy risk (maines2023understandingthepathogenesis pages 1-2, riverabarahona2018identificationof34 pages 1-5)
Substrate specificity Primary substrate: propionyl-CoA. Human PCC can also carboxylate acetyl-CoA at a much lower rate, about 1.5% of the propionyl-CoA rate; recent structural work found acetyl-CoA and propionyl-CoA bind in highly similar modes (zhou2024structuralinsightsinto pages 6-7, jitrapakdee2003thebiotinenzyme pages 10-11)
Representative recent structural data High-resolution human PCC cryo-EM structures reported in 2024: apo 3.02 Γ…, propionyl-CoA-bound 2.80 Γ…, with overall structures reported in the 2.29–3.38 Γ… range; PDB entries include 8XL3, 8XL4, 8XL5 (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 11-14, zhou2024structuralinsightsinto pages 9-11)

Table: This table summarizes the core molecular, biochemical, structural, and disease-related properties of human PCCA/propionyl-CoA carboxylase alpha chain. It is useful as a compact reference for functional annotation and for linking enzyme function to propionic acidemia.

2. Enzymatic Function and Reaction Mechanism

PCC catalyzes the ATP-dependent, biotin-mediated carboxylation of propionyl-CoA to produce D-methylmalonyl-CoA, using bicarbonate (HCO₃⁻) as the COβ‚‚ donor (erdal2025aminoacidmetabolism pages 9-10, kelson1996chaperoninmediatedassemblyof pages 1-2). This reaction (EC 6.4.1.3) proceeds via a two-step mechanism characteristic of all biotin-dependent carboxylases:

Step 1 β€” Biotin carboxylation (in the BC domain of the Ξ± subunit): ATP activates bicarbonate to form a carboxyphosphate intermediate, which then transfers its carboxyl group to the N1β€² atom of the covalently attached biotin prosthetic group (zhou2024structuralinsightsinto pages 4-6).

Step 2 β€” Carboxyl transfer (in the CT domain of the Ξ² subunit): The carboxylated biotin swings from the BC domain to the CT domain, where the carboxyl group is transferred to the C-Ξ± of propionyl-CoA, generating D-methylmalonyl-CoA. This process involves decarboxylation of carboxybiotin to produce free COβ‚‚ and activated biotin, followed by deprotonation of the acyl moiety to attack the COβ‚‚ (zhou2024structuralinsightsinto pages 4-6).

Substrate Specificity

PCC exhibits strong selectivity for propionyl-CoA as its primary substrate. However, recent cryo-EM structural analyses have demonstrated that PCC can also carboxylate acetyl-CoA, albeit at a dramatically reduced rateβ€”approximately 1.5% of the propionyl-CoA carboxylation rate (zhou2024structuralinsightsinto pages 6-7). Structural studies revealed that propionyl-CoA and acetyl-CoA bind to PCC with nearly identical binding modes, indicating that the acyl-CoA specificity is largely attributable to subtle differences in interactions mediated by the acyl groups, although these differences were not fully resolved in the available cryo-EM densities (zhou2024structuralinsightsinto pages 6-7, zhou2024structuralinsightsinto pages 4-6). The carboxyltransferase domains of PCC, acetyl-CoA carboxylase, and 3-methylcrotonyl-CoA carboxylase show no sequence identity, underscoring the uniqueness of each enzyme's substrate binding site (jitrapakdee2003thebiotinenzyme pages 10-11).

3. Protein Structure and Domain Architecture

Domain Organization

The PCCA-encoded Ξ± subunit contains three functional domains arranged from N- to C-terminus (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4, jitrapakdee2003thebiotinenzyme pages 4-6):

  • Biotin carboxylase (BC) domain: Located at the N-terminus, this domain contains the ATP-grasp fold and catalyzes the first half-reactionβ€”the ATP-dependent carboxylation of the covalently attached biotin cofactor using bicarbonate as the COβ‚‚ source.

  • BT (BC-CT interaction) domain: An intermediate hub domain that mediates interactions between the BC and CT functional regions.

  • Biotin carboxyl carrier protein (BCCP) domain: Located at the C-terminus, this domain contains the conserved lysine residue to which biotin is covalently attached via an amide bond. The BCCP domain positions the biotinyl group adjacent to the acyl-CoA binding pocket in the CT domain.

The Ξ² subunit (encoded by PCCB) consists solely of the carboxyltransferase (CT) domain, which is divided into CT-N and CT-C subdomains. The CT domain catalyzes the second half-reactionβ€”transfer of the carboxyl group from carboxybiotin to propionyl-CoA (zhou2024structuralinsightsinto pages 4-6).

Holoenzyme Assembly

The PCC holoenzyme assembles as an α₆β₆ dodecamer with a distinctive four-layer architecture: six Ξ² subunits form the core in two layers, with six Ξ± subunits positioned at the top and bottom in two additional layers. Each Ξ± subunit binds to one Ξ² subunit (kelson1996chaperoninmediatedassemblyof pages 1-2, zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 1-4). The assembly of the holoenzyme requires molecular chaperones; studies in E. coli expression systems demonstrated that chaperonin (GroEL/GroES) facilitates proper folding and assembly of both wild-type and mutant PCC subunits (kelson1996chaperoninmediatedassemblyof pages 1-2).

High-Resolution Structures

A major structural advance came in 2024, when Zhou et al. reported the first high-resolution cryo-EM structures of human PCC holoenzyme in multiple states: the apo form at 3.02 Γ… resolution, the propionyl-CoA-bound form (PCC-PCO) at 2.80 Γ… resolution, and the acetyl-CoA-bound form (PCC-ACO) at 3.38 Γ… resolution. These structures have been deposited in the Protein Data Bank (PDB entries 8XL3, 8XL4, 8XL5) (zhou2024structuralinsightsinto pages 4-6, zhou2024structuralinsightsinto pages 11-14, zhou2024structuralinsightsinto pages 9-11). Notably, in all PCC structures analyzed, the covalently linked biotin binds to an exo-site distant (>7 Γ…) from the catalytic residues G437 and A438 in the CT domain, suggesting the enzyme was captured in a catalytically incompetent conformation (zhou2024structuralinsightsinto pages 6-7).

4. Subcellular Localization

PCC functions exclusively in the mitochondrial matrix, where it processes propionyl-CoA generated from multiple catabolic pathways (kelson1996chaperoninmediatedassemblyof pages 1-2). Both the Ξ± and Ξ² subunit precursors contain N-terminal mitochondrial matrix targeting presequences. The Ξ± subunit precursor undergoes proteolytic cleavage at a conserved motif for mitochondrial-targeted protein processing, with the mature Ξ± subunit beginning at approximately residue 26 (kelson1996chaperoninmediatedassemblyof pages 2-3). When expressed with its full-length sequence including the mitochondrial leader in mammalian cells, the Ξ² subunit precursor is correctly transported to mitochondria, confirming the functionality of the targeting sequence (kelson1996chaperoninmediatedassemblyof pages 1-2).

5. Metabolic Pathways and Biochemical Context

The Propionate Metabolism Pathway

PCC occupies a critical position in the propionate catabolism pathway, catalyzing the first committed step in the conversion of propionyl-CoA to succinyl-CoA, a TCA cycle intermediate (erdal2025aminoacidmetabolism pages 9-10). The complete pathway proceeds as follows:

  1. Propionyl-CoA β†’ D-methylmalonyl-CoA (catalyzed by PCC; biotin- and ATP-dependent)
  2. D-methylmalonyl-CoA β†’ L-methylmalonyl-CoA (catalyzed by methylmalonyl-CoA epimerase)
  3. L-methylmalonyl-CoA β†’ Succinyl-CoA (catalyzed by methylmalonyl-CoA mutase, requiring vitamin B₁₂)

Succinyl-CoA then enters the TCA cycle and can support gluconeogenesis (erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9).

Sources of Propionyl-CoA

Propionyl-CoA is generated from multiple metabolic sources (kelson1996chaperoninmediatedassemblyof pages 1-2, erdal2025aminoacidmetabolism pages 9-10, erdal2025aminoacidmetabolism pages 6-9):

  • Branched-chain amino acid catabolism: Isoleucine and valine degradation pathways converge to generate propionyl-CoA
  • Other amino acids: Threonine and methionine catabolism also produce propionyl-CoA
  • Odd-chain fatty acid Ξ²-oxidation: The final three-carbon unit from odd-chain fatty acids yields propionyl-CoA
  • Cholesterol side chain oxidation: Cholesterol metabolism generates propionyl-CoA
  • Gut microbiome-derived propionate: The liver is the primary organ for clearing propionate produced by intestinal bacteria (erdal2025aminoacidmetabolism pages 9-10)

The liver is the dominant organ for propionyl-CoA metabolism, with kidney and pancreas also possessing significant metabolic capacity (lu2026lossofpropionylcoa pages 1-5). In healthy individuals, efficient hepatic propionate metabolism maintains low circulating propionate levels (0.4–5 Β΅M) (chen2025elevatedpropionateand pages 2-3).

Metabolic Consequences of PCCA Deficiency

Studies using CRISPR-edited PCCA-null HepG2 cells have revealed that PCCA deficiency causes widespread metabolic reprogramming beyond simple propionyl-CoA accumulation (lu2026lossofpropionylcoa pages 5-8, lu2026lossofpropionylcoa pages 1-5, lu2026lossofpropionylcoa pages 8-11):

  • Reduced mitochondrial fatty acid oxidation, with decreased incorporation of fatty acid-derived acetyl-CoA into the TCA cycle
  • Impaired pyruvate anaplerosis via pyruvate carboxylase, reducing gluconeogenic and lipogenic capacity
  • Reduced branched-chain amino acid catabolism, evidenced by decreased downstream metabolites
  • CoA and carnitine depletion, as excess propionyl-CoA sequesters these cofactors
  • Accumulation of toxic metabolites including methylcitrate, propionylcarnitine, and propionylglutamate, which impair ammonia detoxification and disrupt the TCA cycle (lu2026lossofpropionylcoa pages 1-5)

6. Disease Association: Propionic Acidemia

Clinical Features

Propionic acidemia (PA; OMIM #606054) is an autosomal recessive inborn error of metabolism caused by biallelic mutations in either PCCA or PCCB, resulting in deficient PCC enzyme activity (maines2023understandingthepathogenesis pages 1-2, riverabarahona2018identificationof34 pages 1-5). The clinical presentation includes:

  • Neonatal/early-onset form: Ketoacidosis, feeding refusal, lethargy, failure to thrive, seizures, and encephalopathy (riverabarahona2018identificationof34 pages 1-5)
  • Late-onset form: Milder presentation with developmental delay
  • Neurological complications: Psychomotor retardation, dystonia, developmental and speech delays, seizures, stroke-like episodes, optic neuropathy, and intellectual disability (chen2025elevatedpropionateand pages 3-4)
  • Cardiac complications: Hypertrophic or dilated cardiomyopathy and acquired long QT syndrome (aLQTS), which are major causes of morbidity and mortality (maines2023understandingthepathogenesis pages 1-2)
  • Other complications: Pancreatitis, hyperammonemia, and hematologic abnormalities (riverabarahona2018identificationof34 pages 1-5)

Pathophysiological Mechanisms

The pathophysiology of PA extends beyond simple metabolite toxicity and involves multiple cellular pathways (maines2023understandingthepathogenesis pages 1-2, maines2023understandingthepathogenesis pages 4-5, chen2025elevatedpropionateand pages 3-4):

  • TCA cycle dysfunction: Decreased succinyl-CoA availability and inhibition of TCA enzymes (pyruvate dehydrogenase, oxoglutarate dehydrogenase, succinyl-CoA ligase) by propionate and methylcitrate
  • Mitochondrial electron transport chain dysfunction: Documented deficiencies in complexes I, III, and IV; propionyl-CoA acts as a mitochondrial toxin impairing oxidative phosphorylation
  • Oxidative stress: Increased reactive oxygen species production; mtDNA depletion and ultrastructural mitochondrial abnormalities
  • Neurological damage: The basal ganglia are particularly vulnerable due to high energy demands; propionate accumulates in GABAergic neurons where it inhibits GABA transaminase, leading to GABA accumulation and lethargy (chen2025elevatedpropionateand pages 7-7)
  • CoQ10 deficiency, carnitine depletion, and epigenetic/miRNA dysregulation also contribute to disease pathology (maines2023understandingthepathogenesis pages 11-13)

7. Current and Emerging Therapeutic Approaches

The following table summarizes current and emerging therapeutic strategies for propionic acidemia:

Therapy type Mechanism Development stage Key findings
Conventional management: dietary protein restriction, carnitine supplementation, metronidazole/other antibiotics Reduces propiogenic substrate load from isoleucine, valine, methionine, threonine and lowers gut microbiota-derived propionate; carnitine promotes formation/excretion of propionylcarnitine and helps maintain carnitine pools Standard of care / established clinical management Current treatment is mainly supportive rather than curative. Dietary restriction, carnitine, and metronidazole/antibiotics are widely used and have improved survival, but many patients still develop chronic complications including neurologic and cardiac disease despite metabolic management (riverabarahona2018identificationof34 pages 1-5, erdal2025aminoacidmetabolism pages 9-10)
Liver transplantation Provides a major new source of functional hepatic PCC activity, increasing systemic propionyl-CoA clearance and reducing recurrent metabolic instability Established option for selected severe patients Considered for severe disease; can stabilize metabolic control and may improve or reverse cardiomyopathy in some patients, but does not fully cure extrahepatic disease and is limited by transplant eligibility and risks (maines2023understandingthepathogenesis pages 1-2, maines2023understandingthepathogenesis pages 13-14)
mRNA-3927 dual mRNA-LNP therapy (encodes PCCA and PCCB) Intravenous lipid nanoparticle delivery of therapeutic mRNAs to liver cells, enabling translation of both PCC subunits and reconstitution of active PCC enzyme Clinical; first-in-human Phase 1/2 with interim results published in Nature (2024) In 16 participants across 5 dose cohorts, 346 IV doses were administered over 15.69 person-years with no dose-limiting toxicities. Among 8 participants with pretreatment metabolic decompensation events, treatment was associated with a 70% reduction in risk; biomarkers including 3-HP, 2-MC, propionylcarnitine, and n-propionylglycine generally decreased after treatment (koeberl2024interimanalysesof pages 1-2, koeberl2024interimanalysesof pages 2-3, koeberl2024interimanalysesof pages 5-6)
Antisense oligonucleotide therapy targeting PCCA pseudoexon Splice-switching ASOs suppress aberrant pseudoexon inclusion in mutant PCCA pre-mRNA to restore normal splicing and rescue enzyme expression/activity Preclinical / experimental personalized RNA therapy Recent work demonstrated modulation of PCCA pseudoexon splicing as a plausible mutation-specific rescue strategy, highlighting pseudoexon activation as a therapeutically actionable mechanism in propionic acidemia (chen2025elevatedpropionateand pages 7-7)
Metabolic rerouting approaches Diverts upstream propiogenic flux away from propionyl-CoA production, for example by genetically or pharmacologically reducing valine/isoleucine catabolic steps that feed propionate metabolism Preclinical proof-of-concept In zebrafish models of disorders of propionyl-CoA metabolism, proximal interruption of valine/isoleucine oxidation improved survival and reduced propionate-derived toxic metabolites, supporting metabolic rerouting as a candidate strategy for PA (chen2025elevatedpropionateand pages 7-7)

Table: This table summarizes current and emerging therapeutic approaches for propionic acidemia associated with PCCA deficiency, spanning standard management, transplantation, RNA therapeutics, and experimental metabolic strategies. It is useful for comparing mechanism, maturity, and evidence across interventions.

mRNA-3927: A Landmark Clinical Advance

The most significant recent therapeutic development for PA is the first-in-human phase 1/2 clinical trial of mRNA-3927, a dual mRNA therapy encapsulated in lipid nanoparticles (LNPs) that encodes both human PCCA and PCCB subunits. As reported in Nature in April 2024, the interim analysis enrolled 16 participants across 5 dose cohorts (0.30–0.90 mg/kg administered intravenously every 2–3 weeks) (koeberl2024interimanalysesof pages 1-2, koeberl2024interimanalysesof pages 2-3). Key findings include:

  • A total of 346 intravenous doses were administered over 15.69 person-years of treatment
  • No dose-limiting toxicities were observed
  • A 70% reduction in the risk of metabolic decompensation events among the 8 participants who reported them in the 12-month pretreatment period (koeberl2024interimanalysesof pages 1-2)
  • Most patients showed reductions in disease biomarkers (3-hydroxypropionate, 2-methylcitrate, propionylcarnitine, and n-propionylglycine) after treatment (koeberl2024interimanalysesof pages 2-3)
  • The most common adverse events were pyrexia (68.8%), diarrhea (50%), and vomiting (50%); infusion-related reactions occurred in 31.3% of participants but were generally grade 1–2 (koeberl2024interimanalysesof pages 2-3)
  • The mRNA was successfully transported into liver cells, enabling protein translation and post-translational modification into the active PCC enzyme (koeberl2024interimanalysesof pages 5-6)

Antisense Oligonucleotide Approaches

An innovative personalized therapeutic strategy involves splice-modulating antisense oligonucleotides (ASOs) targeting a PCCA pseudoexon. The c.1285-1416A>G variant in intron 14 of the PCCA gene activates a pseudoexon, and ASOs designed to suppress this aberrant splicing event have been shown to rescue normal PCCA mRNA expression and enzyme activity in cellular models (chen2025elevatedpropionateand pages 7-7).

8. Evolutionary Context

PCC belongs to the ancient family of biotin-dependent carboxylases, which are widespread across all three domains of life. Phylogenomic analyses suggest that CoA-bearing-substrate carboxylases, including PCC, arose from an ancestral enzyme present in the last common ancestor of Bacteria that could carry out non-specific carboxylation of several CoA-bearing substrates. Eukaryotes most likely acquired their biotin-dependent carboxylases through the mitochondrial endosymbiosis, consistent with the exclusive mitochondrial localization of PCC in eukaryotic cells (jitrapakdee2003thebiotinenzyme pages 4-6). The conserved domain architectureβ€”BC, BCCP, and CT domainsβ€”is shared across PCC, acetyl-CoA carboxylase, 3-methylcrotonyl-CoA carboxylase, and pyruvate carboxylase, reflecting their common evolutionary origin, though the CT domains diverge to accommodate different substrate specificities (jitrapakdee2003thebiotinenzyme pages 4-6, jitrapakdee2003thebiotinenzyme pages 10-11).

9. Summary

PCCA encodes the Ξ± subunit of propionyl-CoA carboxylase, a biotin-dependent mitochondrial matrix enzyme that catalyzes the ATP-dependent carboxylation of propionyl-CoA to D-methylmalonyl-CoA (EC 6.4.1.3). This reaction is the first committed step in the conversion of propionyl-CoA to succinyl-CoA for entry into the TCA cycle. The enzyme functions as an α₆β₆ dodecamer, with the Ξ± subunit housing the biotin carboxylase and biotin carboxyl carrier protein domains, and the Ξ² subunit providing the carboxyltransferase domain. PCC is essential for the catabolism of branched-chain amino acids (isoleucine, valine), threonine, methionine, odd-chain fatty acids, and cholesterol side chains, as well as for clearance of gut-derived propionate. Loss-of-function mutations in PCCA cause propionic acidemia, a severe inborn error of metabolism with multisystem complications including neurological damage, cardiomyopathy, and recurrent metabolic crises. Recent high-resolution cryo-EM structures (2024) have provided unprecedented structural insights, and the landmark mRNA-3927 clinical trial has demonstrated the feasibility of dual mRNA replacement therapy for this devastating disorder.

References

  1. (kelson1996chaperoninmediatedassemblyof pages 1-2): T. L. Kelson, T. Ohura, and J. Kraus. Chaperonin-mediated assembly of wild-type and mutant subunits of human propionyl-coa carboxylase expressed in escherichia coli. Human molecular genetics, 5 3:331-7, Mar 1996. URL: https://doi.org/10.1093/hmg/5.3.331, doi:10.1093/hmg/5.3.331. This article has 37 citations and is from a domain leading peer-reviewed journal.

  2. (kelson1996chaperoninmediatedassemblyof pages 2-3): T. L. Kelson, T. Ohura, and J. Kraus. Chaperonin-mediated assembly of wild-type and mutant subunits of human propionyl-coa carboxylase expressed in escherichia coli. Human molecular genetics, 5 3:331-7, Mar 1996. URL: https://doi.org/10.1093/hmg/5.3.331, doi:10.1093/hmg/5.3.331. This article has 37 citations and is from a domain leading peer-reviewed journal.

  3. (erdal2025aminoacidmetabolism pages 9-10): Ranya Erdal, KΔ±vanΓ§ Birsoy, and Gokhan Unlu. Amino acid metabolism in liver mitochondria: from homeostasis to disease. Metabolites, 15:446, Jul 2025. URL: https://doi.org/10.3390/metabo15070446, doi:10.3390/metabo15070446. This article has 7 citations.

  4. (jitrapakdee2003thebiotinenzyme pages 4-6): Sarawut Jitrapakdee and John Wallace. The biotin enzyme family: conserved structural motifs and domain rearrangements. Jun 2003. URL: https://doi.org/10.2174/1389203033487199, doi:10.2174/1389203033487199. This article has 142 citations and is from a peer-reviewed journal.

  5. (zhou2024structuralinsightsinto pages 4-6): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.

  6. (zhou2024structuralinsightsinto pages 1-4): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.

  7. (erdal2025aminoacidmetabolism pages 6-9): Ranya Erdal, KΔ±vanΓ§ Birsoy, and Gokhan Unlu. Amino acid metabolism in liver mitochondria: from homeostasis to disease. Metabolites, 15:446, Jul 2025. URL: https://doi.org/10.3390/metabo15070446, doi:10.3390/metabo15070446. This article has 7 citations.

  8. (maines2023understandingthepathogenesis pages 1-2): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.

  9. (riverabarahona2018identificationof34 pages 1-5): Ana Rivera-Barahona, Rosa Navarrete, Raquel GarcΓ­a-RodrΓ­guez, Eva Richard, Magdalena Ugarte, Celia PΓ©rez-Cerda, BelΓ©n PΓ©rez, Alejandra GΓ‘mez, and Lourdes R. Desviat. Identification of 34 novel mutations in propionic acidemia: functional characterization of missense variants and phenotype associations. Molecular genetics and metabolism, 125 3:266-275, Nov 2018. URL: https://doi.org/10.1016/j.ymgme.2018.09.008, doi:10.1016/j.ymgme.2018.09.008. This article has 29 citations and is from a peer-reviewed journal.

  10. (zhou2024structuralinsightsinto pages 6-7): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.

  11. (jitrapakdee2003thebiotinenzyme pages 10-11): Sarawut Jitrapakdee and John Wallace. The biotin enzyme family: conserved structural motifs and domain rearrangements. Jun 2003. URL: https://doi.org/10.2174/1389203033487199, doi:10.2174/1389203033487199. This article has 142 citations and is from a peer-reviewed journal.

  12. (zhou2024structuralinsightsinto pages 11-14): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.

  13. (zhou2024structuralinsightsinto pages 9-11): Fayang Zhou, Yuanyuan Zhang, Yuyao Zhu, Qiang Zhou, Yigong Shi, and Qiuyu Hu. Structural insights into human propionyl-coa carboxylase (pcc) and 3-methylcrotonyl-coa carboxylase (mcc). bioRxiv, Aug 2024. URL: https://doi.org/10.1101/2024.04.30.591959, doi:10.1101/2024.04.30.591959. This article has 10 citations.

  14. (lu2026lossofpropionylcoa pages 1-5): Fang Lu, Chorlada Paiboonrungruang, Wentao He, Zhaohui Xiong, Pingchuan Tang, Takhar Kasumov, Xiaoxin Chen, and Guo-Fang Zhang. Loss of propionyl-coa carboxylase reprograms hepatic metabolism by suppressing mitochondrial pyruvate carboxylation and fatty acid oxidation. bioRxiv, Apr 2026. URL: https://doi.org/10.64898/2026.04.13.718201, doi:10.64898/2026.04.13.718201. This article has 0 citations.

  15. (chen2025elevatedpropionateand pages 2-3): Xiaoxin Chen, Qing Cheng, and Guo-Fang Zhang. Elevated propionate and its association with neurological dysfunctions in propionic acidemia. Frontiers in Molecular Neuroscience, Mar 2025. URL: https://doi.org/10.3389/fnmol.2025.1499376, doi:10.3389/fnmol.2025.1499376. This article has 11 citations.

  16. (lu2026lossofpropionylcoa pages 5-8): Fang Lu, Chorlada Paiboonrungruang, Wentao He, Zhaohui Xiong, Pingchuan Tang, Takhar Kasumov, Xiaoxin Chen, and Guo-Fang Zhang. Loss of propionyl-coa carboxylase reprograms hepatic metabolism by suppressing mitochondrial pyruvate carboxylation and fatty acid oxidation. bioRxiv, Apr 2026. URL: https://doi.org/10.64898/2026.04.13.718201, doi:10.64898/2026.04.13.718201. This article has 0 citations.

  17. (lu2026lossofpropionylcoa pages 8-11): Fang Lu, Chorlada Paiboonrungruang, Wentao He, Zhaohui Xiong, Pingchuan Tang, Takhar Kasumov, Xiaoxin Chen, and Guo-Fang Zhang. Loss of propionyl-coa carboxylase reprograms hepatic metabolism by suppressing mitochondrial pyruvate carboxylation and fatty acid oxidation. bioRxiv, Apr 2026. URL: https://doi.org/10.64898/2026.04.13.718201, doi:10.64898/2026.04.13.718201. This article has 0 citations.

  18. (chen2025elevatedpropionateand pages 3-4): Xiaoxin Chen, Qing Cheng, and Guo-Fang Zhang. Elevated propionate and its association with neurological dysfunctions in propionic acidemia. Frontiers in Molecular Neuroscience, Mar 2025. URL: https://doi.org/10.3389/fnmol.2025.1499376, doi:10.3389/fnmol.2025.1499376. This article has 11 citations.

  19. (maines2023understandingthepathogenesis pages 4-5): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.

  20. (chen2025elevatedpropionateand pages 7-7): Xiaoxin Chen, Qing Cheng, and Guo-Fang Zhang. Elevated propionate and its association with neurological dysfunctions in propionic acidemia. Frontiers in Molecular Neuroscience, Mar 2025. URL: https://doi.org/10.3389/fnmol.2025.1499376, doi:10.3389/fnmol.2025.1499376. This article has 11 citations.

  21. (maines2023understandingthepathogenesis pages 11-13): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.

  22. (maines2023understandingthepathogenesis pages 13-14): Evelina Maines, Michele Moretti, Nicola Vitturi, Giorgia Gugelmo, Ilaria Fasan, Livia Lenzini, Giovanni Piccoli, Vincenza Gragnaniello, Arianna Maiorana, Massimo Soffiati, Alberto Burlina, and Roberto Franceschi. Understanding the pathogenesis of cardiac complications in patients with propionic acidemia and exploring therapeutic alternatives for those who are not eligible or are waiting for liver transplantation. Metabolites, 13(4):563, Apr 2023. URL: https://doi.org/10.3390/metabo13040563, doi:10.3390/metabo13040563. This article has 7 citations.

  23. (koeberl2024interimanalysesof pages 1-2): Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, and Stephanie Grunewald. Interim analyses of a first-in-human phase 1/2 mrna trial for propionic acidaemia. Nature, 628:872-877, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07266-7, doi:10.1038/s41586-024-07266-7. This article has 136 citations and is from a highest quality peer-reviewed journal.

  24. (koeberl2024interimanalysesof pages 2-3): Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, and Stephanie Grunewald. Interim analyses of a first-in-human phase 1/2 mrna trial for propionic acidaemia. Nature, 628:872-877, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07266-7, doi:10.1038/s41586-024-07266-7. This article has 136 citations and is from a highest quality peer-reviewed journal.

  25. (koeberl2024interimanalysesof pages 5-6): Dwight Koeberl, Andreas Schulze, Neal Sondheimer, Gerald S. Lipshutz, Tarekegn Geberhiwot, Lerong Li, Rajnish Saini, Junxiang Luo, Vanja Sikirica, Ling Jin, Min Liang, Mary Leuchars, and Stephanie Grunewald. Interim analyses of a first-in-human phase 1/2 mrna trial for propionic acidaemia. Nature, 628:872-877, Apr 2024. URL: https://doi.org/10.1038/s41586-024-07266-7, doi:10.1038/s41586-024-07266-7. This article has 136 citations and is from a highest quality peer-reviewed journal.

Artifacts

Citations

  1. kelson1996chaperoninmediatedassemblyof pages 1-2
  2. zhou2024structuralinsightsinto pages 4-6
  3. zhou2024structuralinsightsinto pages 6-7
  4. jitrapakdee2003thebiotinenzyme pages 10-11
  5. kelson1996chaperoninmediatedassemblyof pages 2-3
  6. erdal2025aminoacidmetabolism pages 9-10
  7. lu2026lossofpropionylcoa pages 1-5
  8. chen2025elevatedpropionateand pages 2-3
  9. chen2025elevatedpropionateand pages 3-4
  10. maines2023understandingthepathogenesis pages 1-2
  11. chen2025elevatedpropionateand pages 7-7
  12. maines2023understandingthepathogenesis pages 11-13
  13. koeberl2024interimanalysesof pages 1-2
  14. koeberl2024interimanalysesof pages 2-3
  15. koeberl2024interimanalysesof pages 5-6
  16. jitrapakdee2003thebiotinenzyme pages 4-6
  17. zhou2024structuralinsightsinto pages 1-4
  18. erdal2025aminoacidmetabolism pages 6-9
  19. zhou2024structuralinsightsinto pages 11-14
  20. zhou2024structuralinsightsinto pages 9-11
  21. lu2026lossofpropionylcoa pages 5-8
  22. lu2026lossofpropionylcoa pages 8-11
  23. maines2023understandingthepathogenesis pages 4-5
  24. maines2023understandingthepathogenesis pages 13-14
  25. https://doi.org/10.1093/hmg/5.3.331,
  26. https://doi.org/10.3390/metabo15070446,
  27. https://doi.org/10.2174/1389203033487199,
  28. https://doi.org/10.1101/2024.04.30.591959,
  29. https://doi.org/10.3390/metabo13040563,
  30. https://doi.org/10.1016/j.ymgme.2018.09.008,
  31. https://doi.org/10.64898/2026.04.13.718201,
  32. https://doi.org/10.3389/fnmol.2025.1499376,
  33. https://doi.org/10.1038/s41586-024-07266-7,

πŸ“š Additional Documentation

Notes

(PCCA-notes.md)

PCCA (P05165) review notes

Schema shape reminders (validated)

  • core_functions.directly_involved_in: multivalued list of Term ({id,label}).
  • suggested_questions: list of {question: "...", experts: [...]}.
  • suggested_experiments: list of {description: "...", hypothesis: "..."}.

Deep research status

just deep-research-falcon human P05165 / uv run scripts/deep_research_wrapper.py
did NOT produce a PCCA-deep-research-falcon.md (falcon wrapper: system python 3.9
chokes on dict | None; run via uv started but produced no output/log within the
poll window). Per instructions I did NOT fabricate a -deep-research-*.md. Grounded
this review in PCCA-uniprot.txt, the seeded GOA, dismech/kb/disorders/Propionic_Acidemia.yaml,
and the cached publications/PMID_*.md.

Core biology (verified)

PCCA = biotin-containing alpha subunit of mitochondrial propionyl-CoA carboxylase (PCC),
a biotin-dependent carboxylase. PCC catalyses the first committed, ATP-dependent step of
propionyl-CoA catabolism: propanoyl-CoA + HCO3- + ATP -> (S)-methylmalonyl-CoA + ADP + Pi
(EC 6.4.1.3; RHEA:23720). Holoenzyme = alpha6beta6 dodecamer (~750 kDa) of PCCA (alpha) +
PCCB (beta) [PMID:20725044, PMID:29033250].

  • alpha subunit (PCCA) carries the biotin carboxylase (BC) + biotin-carboxyl-carrier
    protein (BCCP) domains; biotin is covalently attached at Lys694 by HLCS; alpha
    catalyses the ATP-dependent carboxylation of biotin. beta subunit (PCCB) supplies the
    carboxyltransferase (CT) activity. UniProt: BC domain 62-509, ATP-grasp 181-378,
    biotinyl-binding 653-728; ACT_SITE 349; ATP/Mg2+/Mn2+ binding sites; biotin at 409/694.
  • Substrate: propionyl-CoA (Km 0.29 mM); also butyryl-CoA (-> ethylmalonyl-CoA) at much
    lower rate; minor acetyl-CoA [PMID:6765947, PMID:29033250, UniProt CATALYTIC ACTIVITY].
  • Location: mitochondrial matrix (matrix enzyme; loosely bound to inner membrane-matrix
    fraction) [UniProt SUBCELLULAR LOCATION; PMID:10101253; PMID:16023992; PMID:29033250].
    Cleavable N-terminal transit peptide (1-52) PMID:16023992.
  • Pathway: propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA step 1/3
    (UniPathway UPA00945/UER00908; UniProt PATHWAY). Product methylmalonyl-CoA -> succinyl-CoA,
    a TCA anaplerotic intermediate PMID:29033250.
  • Precursors of propionyl-CoA: cholesterol, valine, odd-chain FA, methionine, isoleucine,
    threonine ("c-VOMIT") PMID:29033250.

Disease

Biallelic PCCA (or PCCB) loss-of-function -> propionic acidemia (PA-1, MIM:606054;
MONDO:0011628) [UniProt DISEASE; PMID:10101253; disorder KB]. Autosomal recessive organic
acidemia; toxic organic acid accumulation, metabolic acidosis, hyperammonemia.

Interactions

  • PCCB (P05166): obligate partner in holoenzyme; multiple IntAct/interactome hits
    (PMID:20725044, PMID:33961781, PMID:40205054). These are the biological complex partner.
  • MCC / MCCC1 (P23508): IntAct hit (PMID:32296183 HuRI). Cross-carboxylase / likely
    systematic Y2H; MCC is a paralogous biotin carboxylase.
  • HLCS / holocarboxylase synthetase (P50747): biotinylates PCCA at K694; PCCA is HLCS
    substrate; enzyme binding (PMID:19157941 uses the PCCA-derived p67 substrate).
  • SIRT3/4/5: deacylate/interact with acetylated biotin-dependent carboxylases including
    PCCA (UniProt SUBUNIT; PMID:23438705 - not in GOA).

Annotation decisions summary

  • MF: GO:0004658 propionyl-CoA carboxylase activity (IBA, IEA, IDA PMID:6765947,
    IMP PMID:8434582) -> ACCEPT (core). biotin binding, ATP binding, metal ion binding -> ACCEPT
    (cofactor/substrate, well supported by structure/UniProt features). ligase forming C-C
    bonds (GO:0016885, IEA) -> ACCEPT parent (correct but general). enzyme binding IPI
    PMID:19157941 (HLCS) -> KEEP_AS_NON_CORE (real, but a modification substrate relationship,
    not core enzymatic function).
  • CC: mitochondrial matrix (multiple IDA/EXP/IEA/TAS) -> ACCEPT. mitochondrion (IBA/IDA/HTP)
    -> ACCEPT (broader but correct). cytosol (Reactome TAS) -> KEEP_AS_NON_CORE (reflects
    cytosolic apo-precursor before import; not functional site). catalytic complex GO:1902494
    (IPI PMID:20725044) -> MODIFY too general; propose propionyl-CoA carboxylase complex.
  • BP: propionate metabolism / propionyl-CoA catabolism. short-chain fatty acid catabolic
    process (GO:0019626, IC) -> MODIFY to propionyl-CoA catabolic process GO:1902859.
    succinyl-CoA biosynthetic process (GO:1901290, IDA PMID:8434582) -> KEEP_AS_NON_CORE
    (downstream product; PCC makes methylmalonyl-CoA, not succinyl-CoA directly). fatty acid
    metabolic process (GO:0006631, NAS) -> KEEP_AS_NON_CORE (broad). branched-chain amino acid
    metabolic process (GO:0009081, NAS) -> KEEP_AS_NON_CORE (Ile/Val/Thr/Met feed in; real
    physiological role but not the direct reaction).
  • protein binding (GO:0005515) IPIs: bare term; MARK_AS_OVER_ANNOTATED (per policy, not REMOVE).
    PMID:20725044/33961781/40205054 = PCCB (the genuine complex partner); PMID:32296183 = MCC/HuRI.

πŸ“„ View Raw YAML

id: P05165
gene_symbol: PCCA
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  PCCA encodes the biotin-containing alpha subunit of mitochondrial propionyl-CoA
  carboxylase (PCC; EC 6.4.1.3), a biotin-dependent carboxylase of the mitochondrial
  matrix. PCC catalyses the first, committed, ATP-dependent step of propionyl-CoA
  catabolism, converting propanoyl-CoA + bicarbonate + ATP into (S)-methylmalonyl-CoA
  + ADP + phosphate; the methylmalonyl-CoA product is subsequently converted to
  succinyl-CoA and enters the tricarboxylic acid cycle. Propionyl-CoA arises from the
  catabolism of the amino acids isoleucine, valine, methionine and threonine, of
  odd-chain fatty acids, and of cholesterol. The functional holoenzyme is a large
  alpha6-beta6 dodecamer (~750 kDa) built from six PCCA (alpha) and six PCCB (beta)
  subunits. The alpha subunit carries the biotin carboxylase (BC) domain and the
  C-terminal biotin-carboxyl-carrier-protein (BCCP) domain to which biotin is
  covalently attached (at Lys694, by holocarboxylase synthetase); it binds ATP and
  bicarbonate and catalyses the Mg2+-dependent carboxylation of biotin, whereas the
  beta subunit (PCCB) supplies the carboxyltransferase activity that transfers the
  carboxyl group to propionyl-CoA. The alpha subunit is synthesized with a cleavable
  N-terminal mitochondrial targeting presequence and matures in the matrix. Loss of
  PCC activity through biallelic pathogenic variants in PCCA (or PCCB) causes propionic
  acidemia, an autosomal recessive organic acidemia.
alternative_products:
- name: '1'
  id: P05165-1
- name: '2'
  id: P05165-2
  sequence_note: VSP_039857
- name: '3'
  id: P05165-3
  sequence_note: VSP_044458
existing_annotations:
- term:
    id: GO:0004658
    label: propionyl-CoA carboxylase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetically inferred propionyl-CoA carboxylase activity. This is the core,
      defining molecular function of PCCA as the biotin-containing alpha subunit of the
      PCC holoenzyme, directly supported by biochemistry and disease genetics.
    action: ACCEPT
    reason: >-
      Well-supported core function; the IBA is at the correct level of specificity and
      concordant with experimental (IDA/IMP) annotations and the EC 6.4.1.3 assignment.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation
        of propionyl-CoA to methylmalonyl-CoA and is encoded by the genes PCCA and PCCB
        to form a hetero-dodecamer.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetically inferred mitochondrial localization/activity. Correct: PCC is a
      mitochondrial matrix enzyme.
    action: ACCEPT
    reason: >-
      Consistent with experimental matrix localization (below); mitochondrion is a
      correct, if less specific, compartment for where the enzyme is active.
    supported_by:
    - reference_id: PMID:20725044
      supporting_text: >-
        Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme,
        is essential for the catabolism of the amino acids Thr, Val, Ile and Met,
        cholesterol and fatty acids with an odd number of carbon atoms.
- term:
    id: GO:0004658
    label: propionyl-CoA carboxylase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Electronic (RHEA:23720 / EC 6.4.1.3 mapping) assignment of propionyl-CoA
      carboxylase activity. Redundant with, and confirmed by, the experimental IDA/IMP
      annotations of the same term.
    action: ACCEPT
    reason: >-
      Correct core molecular function; the EC/RHEA mapping matches the demonstrated
      catalytic activity.
    supported_by:
    - reference_id: PMID:6765947
      supporting_text: >-
        We have purified propionyl-CoA carboxylase from normal, postmortem human liver
        to homogeneity.
- term:
    id: GO:0005524
    label: ATP binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro-based ATP binding. The alpha subunit contains an ATP-grasp domain and
      catalyses the ATP-dependent carboxylation of biotin; ATP is a substrate of the BC
      reaction (Km ~0.08 mM).
    action: ACCEPT
    reason: >-
      Supported by the catalytic mechanism, the ATP-grasp domain, and multiple ATP
      binding-site features in UniProt; ATP binding is integral to the alpha-subunit
      biotin carboxylase step.
    supported_by:
    - reference_id: PMID:6765947
      supporting_text: >-
        The apparent Km values for ATP, propionyl-CoA, and bicarbonate
        are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: located_in
  review:
    summary: >-
      Electronic (UniProt subcellular location / ARBA) assignment of mitochondrial
      matrix. Correct and concordant with experimental EXP/IDA matrix annotations.
    action: ACCEPT
    reason: >-
      PCC is a matrix enzyme; the electronic assignment matches the curated UniProt
      subcellular location and experimental evidence.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
    id: GO:0009374
    label: biotin binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: enables
  review:
    summary: >-
      ARBA electronic assignment of biotin binding. Biotin is the obligate cofactor of
      PCC and is covalently attached to the C-terminal biotinyl domain of the alpha
      subunit; each holoenzyme carries biotin almost entirely on the alpha subunit.
    action: ACCEPT
    reason: >-
      Strongly supported: biotin is the defining cofactor of this biotin-dependent
      carboxylase and is carried by PCCA.
    supported_by:
    - reference_id: PMID:6765947
      supporting_text: >-
        Each mole of native enzyme
        contains 4 mol of bound biotin, virtually all of which is found with the larger
        (alpha) subunit.
- term:
    id: GO:0016885
    label: ligase activity, forming carbon-carbon bonds
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  qualifier: enables
  review:
    summary: >-
      ARBA electronic assignment of the parent ligase term. This is the correct broad
      catalytic class (EC 6.4 ligases forming C-C bonds) for propionyl-CoA carboxylase,
      but is less informative than the specific GO:0004658 already annotated.
    action: ACCEPT
    reason: >-
      Correct parent activity; not wrong, but subsumed by the more specific
      propionyl-CoA carboxylase activity. Retained as a valid, if general, IEA.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        Propionyl-CoA carboxylase (PCC) is the enzyme which catalyzes the carboxylation
        of propionyl-CoA to methylmalonyl-CoA
- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro-based metal ion binding. The alpha-subunit biotin carboxylase/ATP-grasp
      domain binds two divalent metal ions (Mg2+ or Mn2+) per subunit that are required
      for the ATP-dependent carboxylation step.
    action: ACCEPT
    reason: >-
      Supported by UniProt cofactor annotation (binds 2 Mg2+/Mn2+ per subunit) and
      metal-binding site features; a general but correct molecular function.
    supported_by:
    - reference_id: PMID:20725044
      supporting_text: >-
        The active site of the BC domain is conserved with that of E. coli BC, and all
        the residues that interact with the substrates of this reaction have essentially
        the same conformation in both structures
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20725044
  qualifier: enables
  review:
    summary: >-
      IntAct-curated binary interaction with PCCB (P05166), the beta subunit. This is
      the genuine, obligate holoenzyme partnership (alpha6-beta6), but the bare
      "protein binding" term is uninformative about the actual molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Per curation policy, bare protein binding IPIs are not removed. The interaction
      itself (with PCCB) is real and biologically central, but "protein binding" adds no
      functional specificity beyond what is captured by the propionyl-CoA carboxylase
      complex membership; a more informative term (structural constituent of the PCC
      holoenzyme) would be preferable.
    supported_by:
    - reference_id: PMID:20725044
      supporting_text: >-
        The holoenzyme of PCC
        is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      IntAct/HuRI systematic binary interactome hit, here with MCC (MCCC1, P23508), a
      paralogous biotin-dependent carboxylase. Bare "protein binding" from a
      high-throughput all-by-all screen.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Uninformative term from a proteome-scale Y2H screen; not the core function.
      Retained per policy (not removed) but flagged as over-annotation.
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: >-
        Here we present a human 'all-by-all'
        reference interactome map of human binary protein interactions, or 'HuRI'.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  qualifier: enables
  review:
    summary: >-
      IntAct-curated interaction with PCCB (P05166) from a proteome-scale interactome
      study (BioPlex-type). Again the genuine beta-subunit partner, reported via the
      uninformative "protein binding" term.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Real interaction (PCCB, the holoenzyme partner) but bare protein binding is not
      the core molecular function; retained per policy and flagged as over-annotation.
    supported_by:
    - reference_id: PMID:33961781
      supporting_text: Dual proteome-scale networks reveal cell-specific remodeling of the human
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:40205054
  qualifier: enables
  review:
    summary: >-
      IntAct-curated interaction with PCCB (P05166) from a multimodal cell-map / genomics
      study. The beta-subunit partner again, via bare "protein binding".
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Genuine PCCB partnership but uninformative term; retained per policy and flagged
      as over-annotation rather than removed.
    supported_by:
    - reference_id: PMID:40205054
      supporting_text: Multimodal cell maps as a foundation for structural and functional genomics.
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: >-
      Immunofluorescence (Human Protein Atlas) localization to mitochondrion. Correct,
      if less specific than the matrix annotations.
    action: ACCEPT
    reason: >-
      Direct localization evidence consistent with PCC being a mitochondrial matrix
      enzyme.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: NAS
  original_reference_id: PMID:29033250
  qualifier: located_in
  review:
    summary: >-
      ComplexPortal (CPX-6169) NAS assignment of mitochondrial matrix, from the PCC
      review. Correct compartment for the holoenzyme.
    action: ACCEPT
    reason: >-
      Concordant with experimental EXP/IDA matrix evidence and the curated UniProt
      subcellular location.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
    id: GO:0006631
    label: fatty acid metabolic process
  evidence_type: NAS
  original_reference_id: PMID:29033250
  qualifier: involved_in
  review:
    summary: >-
      ComplexPortal NAS: PCC participates in fatty acid metabolism, since propionyl-CoA
      is the end product of beta-oxidation of odd-chain fatty acids and PCC channels it
      into the TCA cycle. Broad process term.
    action: KEEP_AS_NON_CORE
    reason: >-
      Real but non-core physiological context. PCC acts on the propionyl-CoA node of
      odd-chain fatty acid catabolism; the direct reaction is more precisely
      propionyl-CoA carboxylation/propionate catabolism than generic fatty acid
      metabolism.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        Disruption of PCC leads to accumulation of odd-chain fatty acids (FA), as
        propionyl-CoA is the end product of beta oxidation of odd-numbered FA.
- term:
    id: GO:0009081
    label: branched-chain amino acid metabolic process
  evidence_type: NAS
  original_reference_id: PMID:29033250
  qualifier: involved_in
  review:
    summary: >-
      ComplexPortal NAS: PCC is downstream in the catabolism of branched-chain and other
      amino acids (isoleucine, valine, methionine, threonine) that generate propionyl-CoA.
    action: KEEP_AS_NON_CORE
    reason: >-
      Valid physiological role (Ile and Val catabolism converge on propionyl-CoA), but
      not the direct reaction PCCA catalyses; kept as a relevant non-core process.
      Note GO:0009081 covers isoleucine/leucine/valine; PCC also serves Met/Thr, which
      are not branched-chain, so this term is a partial view of PCC's amino-acid role.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        Propionyl-CoA is produced by catabolism of cholesterol, valine, odd chain fatty
        acids, methionine, isoleucine and threonine
- term:
    id: GO:1902494
    label: catalytic complex
  evidence_type: IPI
  original_reference_id: PMID:20725044
  qualifier: part_of
  review:
    summary: >-
      ComplexPortal IPI: PCCA is part of a catalytic complex, i.e. the alpha6-beta6 PCC
      holoenzyme (ComplexPortal CPX-6169, Mitochondrial propionyl-CoA carboxylase complex).
    action: ACCEPT
    reason: >-
      Correct: PCCA is an obligate structural subunit of the catalytic PCC holoenzyme.
      A dedicated "propionyl-CoA carboxylase complex" GO term does not currently exist
      (only acetyl-CoA and methylcrotonoyl-CoA carboxylase complexes), so the general
      "catalytic complex" is retained rather than modified to a nonexistent term.
    supported_by:
    - reference_id: PMID:20725044
      supporting_text: >-
        The holoenzyme of PCC
        is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: EXP
  original_reference_id: PMID:10101253
  qualifier: located_in
  review:
    summary: >-
      Experimental import/localization: in vitro-expressed PCCA precursor is imported
      into mitochondria and processed to the mature matrix form. Supports mitochondrial
      matrix localization.
    action: ACCEPT
    reason: >-
      Direct experimental evidence for mitochondrial import and maturation, consistent
      with the matrix location of the enzyme.
    supported_by:
    - reference_id: PMID:10101253
      supporting_text: >-
        Both wild-type and mutant proteins were imported into
        mitochondria and processed into the mature form with similar efficiency
- term:
    id: GO:1901290
    label: succinyl-CoA biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:8434582
  qualifier: involved_in
  review:
    summary: >-
      IDA (propionate-flux complementation) linking PCCA to production of succinyl-CoA.
      PCC catalyses the first step (propionyl-CoA -> methylmalonyl-CoA); succinyl-CoA is
      the downstream product of the three-step propanoyl-CoA degradation pathway.
    action: KEEP_AS_NON_CORE
    reason: >-
      PCC's direct product is (S)-methylmalonyl-CoA, not succinyl-CoA; succinyl-CoA
      formation requires the downstream MCEE and MUT steps. The annotation reflects
      PCCA's contribution to the pathway output rather than its direct catalytic
      product, so it is kept as non-core.
    supported_by:
    - reference_id: PMID:8434582
      supporting_text: >-
        Both
        clones reconstitute propionate flux to normal levels in fibroblasts from
        patients genetically deficient in PCCA (pccA).
- term:
    id: GO:0005739
    label: mitochondrion
  evidence_type: HTP
  original_reference_id: PMID:34800366
  qualifier: located_in
  review:
    summary: >-
      High-throughput mitochondrial proteomics assignment to mitochondrion. Concordant
      with the established mitochondrial matrix localization.
    action: ACCEPT
    reason: >-
      High-confidence mitochondrial proteome evidence consistent with the curated
      compartment; correct though less specific than matrix.
    supported_by:
    - reference_id: PMID:34800366
      supporting_text: Quantitative high-confidence human mitochondrial proteome and its dynamics
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: IDA
  original_reference_id: PMID:16023992
  qualifier: located_in
  review:
    summary: >-
      Direct evidence: the mature PCCA amino-terminus and cleavable N-terminal targeting
      presequence were defined, showing import into the mitochondrial matrix by the
      classical presequence pathway.
    action: ACCEPT
    reason: >-
      Experimental determination of the mitochondrial targeting signal and mature matrix
      peptide directly supports matrix localization.
    supported_by:
    - reference_id: PMID:16023992
      supporting_text: >-
        the two subunits of the enzyme (MCCalpha; MCCbeta)
        are imported into the mitochondrial matrix by the classical pathway involving
        cleavable amino-terminal targeting presequences.
- term:
    id: GO:0004658
    label: propionyl-CoA carboxylase activity
  evidence_type: IDA
  original_reference_id: PMID:6765947
  qualifier: enables
  review:
    summary: >-
      Direct biochemical demonstration: PCC purified from human liver to homogeneity,
      shown to be a biotin-containing alpha/beta enzyme carboxylating propionyl-CoA with
      defined kinetic parameters. Core molecular function.
    action: ACCEPT
    reason: >-
      Definitive experimental evidence for propionyl-CoA carboxylase activity; anchors
      this as the core function of the enzyme.
    supported_by:
    - reference_id: PMID:6765947
      supporting_text: >-
        The apparent Km values for ATP, propionyl-CoA, and bicarbonate
        are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
- term:
    id: GO:0019626
    label: short-chain fatty acid catabolic process
  evidence_type: IC
  original_reference_id: PMID:6765947
  qualifier: involved_in
  review:
    summary: >-
      Curator inference (from GO:0004658) that PCC participates in short-chain fatty acid
      catabolism. Propionate/propionyl-CoA is a short-chain acid, but a more precise
      process term is available.
    action: MODIFY
    reason: >-
      The reaction PCC catalyses is specifically the committed step of propionyl-CoA
      catabolism; "short-chain fatty acid catabolic process" is broader and less
      accurate than the dedicated term. Propose replacement with propionyl-CoA catabolic
      process.
    proposed_replacement_terms:
    - id: GO:1902859
      label: propionyl-CoA catabolic process
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        PCC's
        primary function is to catalyze the carboxylation of propionyl-CoA to produce
        methylmalonyl-CoA
- term:
    id: GO:0019626
    label: short-chain fatty acid catabolic process
  evidence_type: IC
  original_reference_id: PMID:8434582
  qualifier: involved_in
  review:
    summary: >-
      Second curator inference (from GO:0004658) of short-chain fatty acid catabolism,
      based on the propionate-flux complementation study. Same over-broad term as above.
    action: MODIFY
    reason: >-
      As above, the direct process is propionyl-CoA / propionate catabolism; replace the
      broad short-chain fatty acid term with the specific propionyl-CoA catabolic process.
    proposed_replacement_terms:
    - id: GO:1902859
      label: propionyl-CoA catabolic process
    supported_by:
    - reference_id: PMID:8434582
      supporting_text: >-
        Both
        clones reconstitute propionate flux to normal levels in fibroblasts from
        patients genetically deficient in PCCA (pccA).
- term:
    id: GO:0004658
    label: propionyl-CoA carboxylase activity
  evidence_type: IMP
  original_reference_id: PMID:8434582
  qualifier: enables
  review:
    summary: >-
      IMP: recombinant human PCCA rescues (complements) the propionate-flux defect in
      PCCA-deficient (pccA) patient fibroblasts, demonstrating that PCCA is required for
      propionyl-CoA carboxylase activity in cells. Core molecular function.
    action: ACCEPT
    reason: >-
      Genetic complementation directly ties PCCA to the propionyl-CoA carboxylase
      activity and propionate flux; strong support for the core function.
    supported_by:
    - reference_id: PMID:8434582
      supporting_text: >-
        We describe cDNA clones expressing
        human PCCA and complementation of the genetic defect in pccA fibroblasts by
        DNA-mediated gene transfer.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-2993447
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS placing PCCA in the cytosol, reflecting the pre-import apo-precursor
      and the Reactome "HLCS biotinylates 6x(PCCA:PCCB)" / cytosolic-to-matrix
      translocation events. PCC is not catalytically active in the cytosol.
    action: KEEP_AS_NON_CORE
    reason: >-
      The functional, biotinylated, active holoenzyme resides in the mitochondrial
      matrix; the cytosolic assignment reflects the transient apo-precursor stage before
      mitochondrial import (any cytosolic biotinylation is likely non-functional). Kept
      as a non-core, transient localization rather than removed.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        The PCCA precursor does not contain biotin until imported into the mitochondrion
        and cleaved
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3323111
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS (cytosolic carboxylases translocate to mitochondrial matrix) placing
      the PCCA precursor in the cytosol prior to import.
    action: KEEP_AS_NON_CORE
    reason: >-
      As above: transient pre-import cytosolic localization of the apo-precursor; the
      active enzyme is a matrix enzyme. Non-core.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        The PCCA precursor does not contain biotin until imported into the mitochondrion
        and cleaved
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9035990
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS (defective HLCS does not biotinylate 6x(PCCA:PCCB)) placing PCCA in
      the cytosol as part of the biotinylation/multiple-carboxylase-deficiency pathway.
    action: KEEP_AS_NON_CORE
    reason: >-
      Same transient cytosolic apo-precursor context; not the functional compartment.
      Kept as non-core.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        The PCCA precursor does not contain biotin until imported into the mitochondrion
        and cleaved
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3065959
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS assignment of mitochondrial matrix (from the carboxylase degradation
      reaction). Correct functional compartment.
    action: ACCEPT
    reason: >-
      Concordant with experimental matrix evidence; the mature active enzyme is in the
      matrix.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3323111
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS assignment of mitochondrial matrix (post-translocation destination in
      the cytosol->matrix translocation reaction). Correct functional compartment.
    action: ACCEPT
    reason: >-
      Matches the established matrix localization of the mature enzyme.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
    id: GO:0005759
    label: mitochondrial matrix
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-71031
  qualifier: located_in
  review:
    summary: >-
      Reactome TAS assignment of mitochondrial matrix, associated with the core PCC
      reaction (propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + Pi). This is
      the compartment where the catalytic reaction occurs.
    action: ACCEPT
    reason: >-
      Correct: the propionyl-CoA carboxylase reaction takes place in the mitochondrial
      matrix.
    supported_by:
    - reference_id: PMID:29033250
      supporting_text: >-
        It is often described as a matrix enzyme because it can dissociate with sonication.
- term:
    id: GO:0019899
    label: enzyme binding
  evidence_type: IPI
  original_reference_id: PMID:19157941
  qualifier: enables
  review:
    summary: >-
      IPI interaction with holocarboxylase synthetase (HLCS, P50747), the enzyme that
      covalently attaches biotin to PCCA. The study used the PCCA-derived C-terminal p67
      polypeptide (biotinylation site K669/K694) as the HLCS substrate in Y2H and docking
      assays, defining the PCCA-HLCS substrate-enzyme interaction.
    action: KEEP_AS_NON_CORE
    reason: >-
      A real and biologically meaningful interaction (PCCA is the substrate of HLCS-
      mediated biotinylation, essential for activity), but it describes a
      post-translational modification relationship rather than PCCA's own core molecular
      function. "Enzyme binding" is more informative than bare protein binding, so it is
      retained as non-core.
    supported_by:
    - reference_id: PMID:19157941
      supporting_text: >-
        The polypeptide p67 comprises the 67 C-terminal amino acids in human PCC (GenBank
        accession #AAA60035), including the biotin-binding site K669
- term:
    id: GO:0009374
    label: biotin binding
  evidence_type: TAS
  original_reference_id: PMID:3460076
  qualifier: enables
  review:
    summary: >-
      TAS (ProtInc) biotin binding, from the cDNA-cloning paper that identified the
      alpha chain via its conserved Ala-Met-Lys-Met biotin-binding-site motif. Biotin is
      the obligate cofactor carried by PCCA.
    action: ACCEPT
    reason: >-
      Well-established core cofactor relationship; the alpha chain was in fact identified
      through its biotin-binding-site sequence.
    supported_by:
    - reference_id: PMID:3460076
      supporting_text: >-
        One class contained the anticipated Ala-Met-Lys-Met
        sequence, corresponding to the biotin binding site found in several
        biotin-dependent carboxylases, thus confirming the alpha-chain assignment of
        these clones.
core_functions:
- description: >-
    Propionyl-CoA carboxylase alpha subunit: within the alpha6-beta6 PCC holoenzyme, the
    alpha subunit binds ATP and bicarbonate and catalyses the Mg2+-dependent ATP-driven
    carboxylation of its covalently bound biotin, contributing the biotin carboxylase
    half-reaction of propionyl-CoA carboxylase activity (conversion of propanoyl-CoA to
    (S)-methylmalonyl-CoA), the first committed step of propionyl-CoA / propionate
    catabolism in the mitochondrial matrix.
  molecular_function:
    id: GO:0004658
    label: propionyl-CoA carboxylase activity
  directly_involved_in:
  - id: GO:1902859
    label: propionyl-CoA catabolic process
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:6765947
    supporting_text: >-
      The apparent Km values for ATP, propionyl-CoA, and bicarbonate
      are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
  - reference_id: PMID:29033250
    supporting_text: >-
      PCC's
      primary function is to catalyze the carboxylation of propionyl-CoA to produce
      methylmalonyl-CoA
- description: >-
    Biotin cofactor carrier: the alpha subunit carries the C-terminal biotinyl (BCCP)
    domain and binds biotin, which is covalently attached (by holocarboxylase synthetase)
    and is obligately required for catalytic activity of the biotin-dependent carboxylase.
  molecular_function:
    id: GO:0009374
    label: biotin binding
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:6765947
    supporting_text: >-
      Each mole of native enzyme
      contains 4 mol of bound biotin, virtually all of which is found with the larger
      (alpha) subunit.
- description: >-
    ATP binding: the alpha subunit ATP-grasp/biotin carboxylase domain binds ATP (Km
    ~0.08 mM) as a substrate of the ATP-dependent biotin carboxylation step.
  molecular_function:
    id: GO:0005524
    label: ATP binding
  locations:
  - id: GO:0005759
    label: mitochondrial matrix
  supported_by:
  - reference_id: PMID:6765947
    supporting_text: >-
      The apparent Km values for ATP, propionyl-CoA, and bicarbonate
      are 0.08 mM, 0.29 mM, and 3.0 mM, respectively.
proposed_new_terms: []
suggested_questions:
- question: >-
    Do the three PCCA splice isoforms (P05165-1/-2/-3) differ in enzymatic function,
    holoenzyme incorporation, or tissue distribution? Their functional impact has not
    been well characterized.
- question: >-
    Does PCCA (or the PCC holoenzyme) have any moonlighting or regulatory role beyond
    carboxylation, e.g. via its reported acetylation/succinylation and interactions with
    SIRT3/4/5?
suggested_experiments:
- description: >-
    Isoform-resolved enzyme kinetics and holoenzyme-assembly assays for P05165-2 and
    P05165-3 versus the canonical isoform, to determine whether alternative splicing
    alters propionyl-CoA carboxylase activity.
- description: >-
    Quantitative biotinylation/acylation site mapping of PCCA in matched control and
    propionic-acidemia cells to test how post-translational modification state modulates
    PCC activity.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10101253
  title: Genetic heterogeneity in propionic acidemia patients with alpha-subunit defects.
    Identification of five novel mutations, one of them causing instability of the
    protein.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified; provides experimental mitochondrial import/maturation and
      PA-causing PCCA variant data. Supports the EXP mitochondrial-matrix annotation.
- id: PMID:16023992
  title: Mitochondrial targeting signals and mature peptides of 3-methylcrotonyl-CoA
    carboxylase.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Focuses on MCC but the abstract explicitly reports the mitochondrial targeting
      signal and mature N-terminus of propionyl-CoA carboxylase as a paralog; supports
      the matrix-import IDA for PCCA.
- id: PMID:19157941
  title: N- and C-terminal domains in human holocarboxylase synthetase participate
    in substrate recognition.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Uses the PCCA-derived C-terminal p67 (biotinylation site) as the HLCS substrate;
      documents the PCCA-HLCS enzyme-substrate interaction underlying the enzyme-binding
      annotation.
- id: PMID:20725044
  title: Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme
    A carboxylase.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Defines the alpha6-beta6 holoenzyme architecture, BC/BCCP/BT domains of the alpha
      subunit, and BC active site; the source of the PCCB-interaction and catalytic-complex
      annotations.
- id: PMID:29033250
  title: Propionyl-CoA carboxylase - A review.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Authoritative review of PCC structure, function, mechanism, localization, and
      disease; primary basis for the description and process/localization judgments.
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      HuRI all-by-all binary interactome; source of a systematic PCCA-MCC(MCCC1) hit
      reported as bare protein binding. Not informative about core function.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human
    interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Proteome-scale interactome study; source of a PCCA-PCCB protein-binding hit. The
      interaction (beta subunit) is genuine but the term is uninformative.
- id: PMID:3460076
  title: 'Isolation of cDNA clones coding for the alpha and beta chains of human propionyl-CoA
    carboxylase: chromosomal assignments and DNA polymorphisms associated with PCCA
    and PCCB genes.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Identified the PCCA (alpha) cDNA via the conserved biotin-binding-site motif;
      supports the biotin-binding TAS annotation.
- id: PMID:34800366
  title: Quantitative high-confidence human mitochondrial proteome and its dynamics
    in cellular context.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      High-confidence mitochondrial proteome; independent HTP evidence for mitochondrial
      localization of PCCA.
- id: PMID:40205054
  title: Multimodal cell maps as a foundation for structural and functional genomics.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Multimodal cell-map genomics resource; source of a PCCA-PCCB protein-binding hit.
      Genuine partner, uninformative term.
- id: PMID:6765947
  title: Isolation and characterization of propionyl-CoA carboxylase from normal human
    liver. Evidence for a protomeric tetramer of nonidentical subunits.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Definitive biochemical characterization of purified human PCC: biotin content on the
      alpha subunit, kinetic parameters for ATP/propionyl-CoA/bicarbonate, substrate range.
      Primary support for the catalytic-activity, cofactor and ATP-binding core functions.
- id: PMID:8434582
  title: Cloning of functional alpha propionyl CoA carboxylase and correction of enzyme
    deficiency in pccA fibroblasts.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Functional cloning and complementation of PCCA-deficient fibroblasts restoring
      propionate flux; support for the IMP propionyl-CoA carboxylase and pathway annotations.
- id: Reactome:R-HSA-2993447
  title: HLCS biotinylates 6x(PCCA:PCCB)
  findings: []
- id: Reactome:R-HSA-3065959
  title: An unknown protease degrades hCBXs
  findings: []
- id: Reactome:R-HSA-3323111
  title: Cytosolic carboxylases translocate to mitochondrial matrix
  findings: []
- id: Reactome:R-HSA-71031
  title: propionyl-CoA + CO2 + ATP <=> D-methylmalonyl-CoA + ADP + orthophosphate
  findings: []
- id: Reactome:R-HSA-9035990
  title: Defective HLCS does not biotinylate 6x(PCCA:PCCB)
  findings: []